Literature DB >> 8005194

Ivermectin levels in human breast milk.

J E Ogbuokiri, B C Ozumba, P O Okonkwo.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1994        PMID： 8005194     DOI： 10.1007/BF00195923

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN： 0031-6970            Impact factor:   2.953


× No keyword cloud information.
  12 in total

1.  Adverse events following mass ivermectin therapy for onchocerciasis.

Authors:  C P Chijioke; P O Okonkwo
Journal:  Trans R Soc Trop Med Hyg       Date:  1992 May-Jun       Impact factor: 2.184

2.  Treatment of onchocerciasis with ivermectin in Sierra Leone.

Authors:  J Whitworth
Journal:  Parasitol Today       Date:  1992-04

3.  Comparison of the effects of a single dose and of four six-monthly doses of ivermectin on adult Onchocerca volvulus.

Authors:  B O Duke; G Zea-Flores; J Castro; E W Cupp; B Munoz
Journal:  Am J Trop Med Hyg       Date:  1991-07       Impact factor: 2.345

4.  Tolerance of single high-dose ivermectin for treatment of lymphatic filariasis.

Authors:  D G Addiss; M L Eberhard; P J Lammie; W L Hitch; H C Spencer
Journal:  Trans R Soc Trop Med Hyg       Date:  1991 Mar-Apr       Impact factor: 2.184

5.  The relative systemic availability of ivermectin after administration as capsule, tablet, and oral solution.

Authors:  G Edwards; A Dingsdale; N Helsby; M L Orme; A M Breckenridge
Journal:  Eur J Clin Pharmacol       Date:  1988       Impact factor: 2.953

6.  Efficacy and tolerance of ivermectin in human onchocerciasis.

Authors:  M A Aziz; S Diallo; I M Diop; M Lariviere; M Porta
Journal:  Lancet       Date:  1982-07-24       Impact factor: 79.321

7.  Ivermectin binds avidly to plasma proteins.

Authors:  U Klotz; J E Ogbuokiri; P O Okonkwo
Journal:  Eur J Clin Pharmacol       Date:  1990       Impact factor: 2.953

8.  Community-based treatment of onchocerciasis with ivermectin: acceptability and early adverse reactions.

Authors:  M C Pacque; Z Dukuly; B M Greene; B Munoz; E Keyvan-Larijani; P N Williams; H R Taylor
Journal:  Bull World Health Organ       Date:  1989       Impact factor: 9.408

9.  Double-blind study of ivermectin and diethylcarbamazine in African onchocerciasis patients with ocular involvement.

Authors:  M Lariviere; P Vingtain; M Aziz; B Beauvais; D Weimann; F Derouin; J Ginoux; H Schulz-Key; P Gaxotte; D Basset
Journal:  Lancet       Date:  1985-07-27       Impact factor: 79.321

10.  Protein binding and ivermectin estimations in patients with onchocerciasis.

Authors:  P O Okonkwo; J E Ogbuokiri; E Ofoegbu; U Klotz
Journal:  Clin Pharmacol Ther       Date:  1993-04       Impact factor: 6.875
View more
  2 in total

Review 1.  Systemic and Target-Site Pharmacokinetics of Antiparasitic Agents.

Authors:  Valentin Al Jalali; Markus Zeitlinger
Journal:  Clin Pharmacokinet       Date:  2020-07       Impact factor: 6.447

Review 2.  A public health response against Strongyloides stercoralis: time to look at soil-transmitted helminthiasis in full.

Authors:  Alejandro J Krolewiecki; Patrick Lammie; Julie Jacobson; Albis-Francesco Gabrielli; Bruno Levecke; Eugenia Socias; Luis M Arias; Nicanor Sosa; David Abraham; Ruben Cimino; Adriana Echazú; Favio Crudo; Jozef Vercruysse; Marco Albonico
Journal:  PLoS Negl Trop Dis       Date:  2013-05-09
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.